Koers Soligenix Inc OTC Bulletin Board
Aandelen
US8342232084
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
23/05 | Sectorupdate: Gezondheidszorgaandelen trekken laat in de middag terug | MT |
23/05 | Sectorupdate: Gezondheidszorgaandelen donderdagmiddag lager | MT |
Omzet 2024 * | 708K 664K | Omzet 2025 * | 900K 843K | Marktkapitalisatie | 4,1 mln. 3,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,49 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,43 mln. | EV/omzet 2024 * | 5,78 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,55 x |
K/w-verhouding 2024 * |
-0,5
x | K/w-verhouding 2025 * |
-0,58
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-06 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 11-09-19 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 06-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-06 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 01-03-09 |
Robert Rubin
BRD | Director/Board Member | 78 | 01-10-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,48% | 124 mld. | |
+17,64% | 111 mld. | |
-11,45% | 23,17 mld. | |
+5,94% | 22,94 mld. | |
-39,94% | 17,42 mld. | |
-10,18% | 17,42 mld. | |
-15,01% | 16,9 mld. | |
+2,69% | 13,71 mld. | |
+28,08% | 11,82 mld. |
- Beurs
- Aandelen
- Koers SNGX
- Koers